Pfizer, BioNTech to up vaccine production to 2.5B doses in 2021

Tuesday, 30. March 2021 12:50

BioNTech SE and Pfizer Inc. will increase the production of their coronavirus vaccine to up to 2.5 billion doses by the end of 2021, BioNTech revealed in its quarterly report on Tuesday. "The increase is driven by the optimization of production processes, the recent initiation of production at BioNTech's Marburg, Germany facility, regulatory approval for six dose vials, and the expansion of our manufacturing and supplier network," the company said.

BioNTech added it is conducting further discussions with potential partners to further expand the manufacturing capacity. It stated 200 million doses of its COVID-19 vaccine have been delivered so far. With Pfizer, it signed orders for 1.4 billion doses for delivery in 2021, and is in talks for additional dose commitments.

Related Links: Pfizer Inc.BioNTech SE
Author:
Breaking the News / DJ